Poxel Announces the Formation of its Scientific Advisory Board for Rare Metabolic Diseases LYON, France–(BUSINESS WIRE)– POXEL SA (Euronext – POXEL – FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for … Continued